In the three or so years since it burst into healthcare, ambient AI scribe technology has run away with the win in the market-uptake race. What has been the return on investment in all those software packages?
Two respected radiology organizations have issued a stark warning on the new recommendations, stating that they risk confusing patients and “may contribute to thousands of additional breast cancer deaths each year.”
"This case reflects a troubling pattern in which payers, dissatisfied with IDR results, increasingly try to attack those outcomes outside the framework Congress created," Rad Partners says.
MGMA says Trump’s immigration policy combined with Congress’s unwillingness to fund additional medical residency positions is a primary driver accelerating the growing U.S. healthcare staffing shortage.
Landiolol, sold under the brand name Rapiblyk, is only meant to be administered in a hospital setting. It was initially approved for adult patients in 2024.
Join us for a Radiology Business webinar and live Q&A on Tuesday, April 21, with leaders from this seven-center imaging group and a veteran financial expert.
In the three or so years since it burst into healthcare, ambient AI scribe technology has run away with the win in the market-uptake race. What has been the return on investment in all those software packages?
